Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Pembrolizumab plus lenalidomide and dexamethasone for pat... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
0
Authors
Saad Usmani
84 more
Saad Usmani
•
Fredrik Schjesvold
82 more
•
Djordje Atanackovic
Published
July 18, 2019
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Haematology
Topics
Medicine
Cancer Oncology
Internal Medicine
Hematology
Surgery
Show all topics
DOI
10.1016/s2352-3026(19)30109-7
